2006 NEWS RELEASES
December 19, 2006 HUMAN GENOME SCIENCES INITIATES PHASE 3 CLINICAL TRIAL OF ALBUFERON® IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
November 27, 2006HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT PIPER JAFFRAY CONFERENCE
November 14, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JMP SECURITIES CONFERENCE
November 14, 2006 HUMAN GENOME SCIENCES ANNOUNCES POSITIVE 76-WEEK RESULTS OF PHASE 2 CLINICAL TRIAL OF LYMPHOSTAT-B IN SYSTEMIC LUPUS ERYTHEMATOSUS
November 8, 2006 HUMAN GENOME SCIENCES ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2006
November 8, 2006 HUMAN GENOME SCIENCES REPORTS INTERIM RESULTS OF PHASE 1B CLINICAL TRIAL OF HGS-ETR1 WITH GEMCITABINE AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS
November 1, 2006 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS THIRD QUARTER 2006 FINANCIAL RESULTS
October 31, 2006HUMAN GENOME SCIENCES REPORTS POSITIVE INTERIM RESULTS OF PHASE 2 TRIALS OF ALBUFERON WITH RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C
October 26, 2006 HUMAN GENOME SCIENCES ANNOUNCES POSITIVE SPECIAL PROTOCOL ASSESSMENT FROM FDA FOR PHASE 3 CLINICAL TRIALS OF LYMPHOSTAT-B IN SYSTEMIC LUPUS ERYTHEMATOSUS
October 19, 2006 HUMAN GENOME SCIENCES APPOINTS KEVIN STARR TO ITS BOARD OF DIRECTORS
October 16, 2006 HUMAN GENOME SCIENCES REPORTS POSITIVE INTERIM QUALITY-OF-LIFE DATA FROM PHASE 2B TRIAL OF ALBUFERON® WITH RIBAVIRIN IN TREATMENT-NAÏVE HEPATITIS C PATIENTS
October 4, 2006 HUMAN GENOME SCIENCES REPORTS SIGNIFICANT PROGRESS AND OUTLINES ITS NEXT STEPS ON THE PATH TO COMMERCIALIZATION
October 4, 2006 HUMAN GENOME SCIENCES ANNOUNCES PHASE 3 CLINICAL DEVELOPMENT PROGRAM FOR ALBUFERON IN CHRONIC HEPATITIS C
September 29, 2006 HUMAN GENOME SCIENCES REPORTS POSITIVE RESULTS OF PHASE 1 CLINICAL TRIAL OF CCR5 MAB IN PATIENTS INFECTED WITH HIV-1
September 27, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATIONS AT ANALYST & INVESTOR MEETING
September 21, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT UBS SECURITIES CONFERENCE
September 13, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANK OF AMERICA CONFERENCE
September 7, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BEAR STEARNS CONFERENCE
August 30, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIOCENTURY-THOMSON FINANCIAL INVESTMENT CONFERENCE
August 29, 2006HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT THOMAS WEISEL PARTNERS INVESTMENT CONFERENCE
August 9, 2006 HUMAN GENOME SCIENCES ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2006
August 9, 2006 HUMAN GENOME SCIENCES ANNOUNCES PHASE 3 CLINICAL DEVELOPMENT PROGRAM FOR LYMPHOSTAT-B IN SYSTEMIC LUPUS ERYTHEMATOSUS
August 3, 2006 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS SECOND QUARTER 2006 FINANCIAL RESULTS
July 20, 2006 HUMAN GENOME SCIENCES INITIATES RANDOMIZED PHASE 2 CLINICAL TRIAL OF HGS-ETR1 IN COMBINATION WITH BORTEZOMIB
July 10, 2006 HUMAN GENOME SCIENCES NAMES TIMOTHY C. BARABE SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
June 22, 2006 HUMAN GENOME SCIENCES ANNOUNCES FULL PRESENTATION OF RESULTS OF PHASE 2 CLINICAL TRIAL OF LYMPHOSTAT-B IN SYSTEMIC LUPUS ERYTHEMATOSUS
June 20, 2006 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS U.S. GOVERNMENT AGREEMENT TO PURCHASE ABTHRAX FOR THE STRATEGIC NATIONAL STOCKPILE
June 20, 2006U.S. GOVERNMENT AGREES TO PURCHASE ABTHRAX FROM HUMAN GENOME SCIENCES FOR THE STRATEGIC NATIONAL STOCKPILE
June 12, 2006 HUMAN GENOME SCIENCES COMPLETES TRANSACTION ESTABLISHING COGENESYS AS AN INDEPENDENT COMPANY
June 12, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT GOLDMAN SACHS CONFERENCE
June 9, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT GOLDMAN SACHS CONFERENCE
June 6, 2006 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS COLLABORATION WITH NOVARTIS FOR DEVELOPMENT AND COMMERCIALIZATION OF ALBUFERON
June 6, 2006 HUMAN GENOME SCIENCES ANNOUNCES COLLABORATION WITH NOVARTIS FOR DEVELOPMENT AND COMMERCIALIZATION OF ALBUFERON
June 2, 2006 HUMAN GENOME SCIENCES NAMES MARGERY B. FISCHBEIN VICE PRESIDENT, BUSINESS DEVELOPMENT & STRATEGIC PLANNING
May 12, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANK OF AMERICA CONFERENCE
May 10, 2006 HUMAN GENOME SCIENCES ANNOUNCES RESULTS FOR FIRST QUARTER OF 2006
May 5, 2006HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT ROBERT W. BAIRD CONFERENCE
May 2, 2006 HUMAN GENOME SCIENCES FACILITIES TRANSACTIONS TO GENERATE $380 MILLION IN ADDITIONAL CASH AVAILABLE FOR OPERATIONS
May 1, 2006HUMAN GENOME SCIENCES PRESENTS INTERIM RESULTS OF PHASE 2 TRIAL OF ALBUFERON WITH RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C WHO FAILED TO RESPOND TO PREVIOUS THERAPY
May 1, 2006HUMAN GENOME SCIENCES PRESENTS INTERIM RESULTS OF PHASE 2B TRIAL OF ALBUFERON® WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
March 14, 2006 HUMAN GENOME SCIENCES TO SPONSOR CONFERENCE CALL TO DISCUSS INTERIM RESULTS OF TWO PHASE 2 TRIALS OF ALBUFERON
March 14, 2006HUMAN GENOME SCIENCES REPORTS POSITIVE INTERIM RESULTS OF PHASE 2 TRIAL OF ALBUFERON IN COMBINATION WITH RIBAVIRIN IN TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS C
March 14, 2006HUMAN GENOME SCIENCES ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2B CLINICAL TRIAL OF ALBUFERON® IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C
March 10, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CITIGROUP CONFERENCE
March 6, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JMP SECURITIES CONFERENCE
February 22, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CITIGROUP CONFERENCE
February 10, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BIO INVESTOR CONFERENCE
February 9, 2006HUMAN GENOME SCIENCES REPORTS FINANCIAL RESULTS FOR FULL YEAR AND FOURTH QUARTER 2005
February 3, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT MERRILL LYNCH CONFERENCE
January 10, 2006 HUMAN GENOME SCIENCES REPORTS ON PROGRESS TOWARD COMMERCIALIZATION AND ANNOUNCES 2006 GOALS AT JPMORGAN HEALTHCARE CONFERENCE
January 10, 2006HUMAN GENOME SCIENCES LICENSES WORLDWIDE INTELLECTUAL PROPERTY RIGHTS FOR TARGET ANTIGEN TO PDL BIOPHARMA
January 10, 2006 HUMAN GENOME SCIENCES RECEIVES MILESTONE PAYMENT FROM GLAXOSMITHKLINE FOR FILING OF GSK716155 IND APPLICATION TO BEGIN PHASE 1 TRIALS IN THE TREATMENT OF DIABETES
January 9, 2006 HUMAN GENOME SCIENCES ANNOUNCES LICENSE AGREEMENT WITH AMGEN
January 6, 2006 HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JPMORGAN CONFERENCE
